Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

NCT06193109 is registered in ClinicalTrials.gov with Burapha University as lead sponsor.

NCT NCT06193109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
Lead sponsor
Burapha University
Phase
Observational
Overall status
Completed
Start date
October 1, 2022
Completion date
July 30, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis and septic shock